DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
MDLN logo

Medline Inc. Stock Price

NasdaqGS:MDLN Community·US$41.6b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 20 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

MDLN Share Price Performance

US$31.96
-9.04 (-22.05%)
​
US$44.62
Fair Value
US$31.96
-9.04 (-22.05%)
28.4% undervalued intrinsic discount
US$44.62
Fair Value
Price US$31.96
AnalystConsensusTarget US$44.62
AnalystHighTarget US$54.33
Thu, 13 Aug 26
Fair ValueUS$44.62
Share Pricen/a

MDLN Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$44.62 28.4% undervalued intrinsic discount

Prime Vendor Contracts And Automation Investments Will Reshape Long Term Earnings Profile

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$54.33 41.2% undervalued intrinsic discount

Expanded Supply Chain Network And Quality Remediation Will Support Stronger Long-Term Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
MDLN logo
Medline
41.2% undervalued intrinsic discount

Expanded Supply Chain Network And Quality Remediation Will Support Stronger Long-Term Prospects

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 3 Sep
Read Narrative
MDLN logo
Medline
28.4% undervalued intrinsic discount

Prime Vendor Contracts And Automation Investments Will Reshape Long Term Earnings Profile

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 13 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystHighTarget
MDLN logo

MDLN: California Distribution Expansion Will Support Future Index Inclusion Upside

Fair Value: US$54.33 41.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
MDLN logo

MDLN: FDA Compliance And Legal Overhang Will Shape Future Upside Potential

Fair Value: US$44.62 28.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with moderate growth potential.

3 Risks
3 Rewards
View Full Analysis

Medline Inc. Key Details

US$29.9b

Revenue

US$22.4b

Cost of Revenue

US$7.5b

Gross Profit

US$6.8b

Other Expenses

US$701.0m

Earnings

Last Reported Earnings
Jun 27, 2026
Next Reporting Earnings
n/a
0.80
25.09%
2.34%
65.9%
View Full Analysis

About MDLN

Founded
1966
Employees
45000
CEO
James Boyle
WebsiteView website
www.medline.com

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon’s gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Recent MDLN News & Updates

Seeking Alpha • Sep 16

Medline: A Tough First Year As A Public Business

Summary Medline continues to deliver strong sales growth, but margin pressure and high leverage persist, challenging the investment case. Despite organic sales guidance being raised to 9-10%, 2026 EBITDA guidance was cut to $3.3-$3.4 billion due to inflation, quality issues, and operational investments. MDLN's net debt remains elevated at $10.1 billion with leverage around 3x, while shares now trade at 23x earnings after a significant price decline. Valuation has become less demanding, but falling margins and persistent adjustments keep the risk-reward unconvincing despite some improvement. Read the full article on Seeking Alpha
User avatar
Narrative Update • Sep 03

MDLN: California Distribution Expansion Will Support Future Index Inclusion Upside

Analysts have trimmed their price target for Medline to about $54 from roughly $56, reflecting slightly adjusted fair value assumptions, a marginally lower discount rate, and updated expectations for revenue growth, profit margins, and future P/E multiples. What’s in the News for Medline Medline signed a new Prime Vendor agreement with Allina Health, giving the Minnesota based health system access to Medline's portfolio of medical surgical products and distribution capabilities across 12 hospital campuses and more than 90 clinics.

Recent updates

No updates

Medline Inc. Competitors

ABT logo

Abbott Laboratories

Symbol: NYSE:ABT
Market cap: US$177.6b
ISRG logo

Intuitive Surgical

Symbol: NasdaqGS:ISRG
Market cap: US$141.9b
MDT logo

Medtronic

Symbol: NYSE:MDT
Market cap: US$117.8b
CVS logo

CVS Health

Symbol: NYSE:CVS
Market cap: US$113.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide